Moderna, Inc.
Moderna, Inc. ( mə-DUR-nə) (founded as ModeRNA Therapeutics, Inc.) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- MRNA [1]
- Listing exchanges
- Nasdaq [1]
- SEC industry
- Biological Products, (No Diagnostic Substances) [1]
- Business sectors
- biotechnology industry; pharmaceutical industry [2]
- Company / filing name
- Moderna, Inc. [1]
- Headquarters location
- Cambridge [2]
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142 [1]
- Founded
- 2010; 2016-07-22 [2]
- Legal form
- Delaware corporation [2]
- Incorporation jurisdiction
- Delaware, United States [1]
- Leadership in background record
- Stéphane Bancel [2]
- Official website
- www.modernatx.com ↗ [2]
- Employees
- 5,800 · reported year 2024 [2]
- Annual revenue
- USD 3,236,000,000 · reported year 2024 [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US60770K1079 [2]
- CIK
- 0001682852 [1]
- SIC code
- 2836 [1]
- Country in background record
- United States [2]
Company positioning and business
Moderna, Inc. ( mə-DUR-nə) (founded as ModeRNA Therapeutics, Inc.) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". [3]
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. [3]
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. [3]
Background text: Wikipedia contributors, Moderna. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Management and corporate governance
The Wikidata background record identifies Stéphane Bancel in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [2]
Understanding company scale
Employees: 5,800 · reported year 2024. [2]
Annual revenue: USD 3,236,000,000 · reported year 2024. [2]
Financial year, securities and disclosures
The SEC submissions record gives Moderna, Inc. a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: MRNA (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Form 10-K filed; reporting period ends 2025-12-31. [5]
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2836. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was Moderna, Inc. founded?
Founded: 2010; 2016-07-22. The linked source provides the background record. [2]
Where is the headquarters of Moderna, Inc.?
Headquarters location: Cambridge. The linked source provides the background record. [2]
Which business sectors are recorded for Moderna, Inc.?
Business sectors: biotechnology industry; pharmaceutical industry. The linked source provides the background record. [2]
Moderna, Inc. relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — Moderna, Inc. filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Moderna (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.